FindTrial
Sign In

Research on sCD163 in sepsis prognosis

sCD163, a potential biomarker for evaluation of sepsis prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-10000812
Enrollment
Unknown
Registered
2010-12-16
Start date
2009-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

1:Collection the blood of 1st, 3st, 5st, 7st, 10st, 14st of patients who were diagnosed with sepsis in ICU

Sponsors

PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age > 18, no limit in gender; 2. a clinical suspectable infection; 3. appearance of two or more features following: (1) body temperature > 38 ? or 90 beats per minute, (3) respiratory rate > 20 times per minutes, (4) peripheral blood WBC > 12.0*10^9 /L or 10%.

Exclusion criteria

Exclusion criteria: fail to obtain informed consent; agranulocytosis ( granolocyte < 0.5*10^9 /L); HIV

Design outcomes

Primary

MeasureTime frame
sCD16;—

Secondary

MeasureTime frame
CRP;wbc;HCT%;TB;—

Countries

China

Contacts

Public ContactLixin Xie
xielx@263.net+86 13911252807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 25, 2026